MedPath

VARICELLA-ZOSTER IMMUNE GLOBULIN (HUMAN)

VARICELLA-ZOSTER IMMUNE GLOBULIN (HUMAN)

Discontinued
DIN Number

02231277

Drug Class

Human

Market Date

Jul 24, 2000

Company
HC

massachusetts public health biologic laboratories

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02231277
AIG Number0115174002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J06BB03 VARICELLA/ZOSTER IMMUNOGLOBULIN
Product Specifications
Dosage FormLiquid
Route of AdministrationIntramuscular
AHFS Classification80:04.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

VARICELLA ZOSTER IMMUNOGLOBULIN (HUMAN)Active
Strength: 100 UNIT / ML
Monograph: VARICELLA ZOSTER IMMUNOGLOBULIN (HUMAN)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.